Willdan (WLDN) Files Rule 144 to Sell 2,763 Restricted Shares via Morgan Stanley
Rhea-AI Filing Summary
Willdan Group, Inc. (WLDN) filed a Rule 144 notice disclosing a proposed sale of 2,763 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $302,358.41. The shares represent part of the company's publicly traded common stock (total shares outstanding reported as 14,665,087) and the seller listed an approximate sale date of 08/15/2025 on the NASDAQ. The shares were acquired from the issuer as restricted stock in three grants: 734 shares on 08/03/2022, 1,294 shares on 06/09/2023, and 735 shares on 08/03/2023; each grant was paid in full on its acquisition date. No securities of the issuer were reported sold by the same person in the past three months in this filing. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider/affiliate sale notice for 2,763 restricted shares valued at $302k, scheduled for mid-August 2025.
This Rule 144 filing is a standard disclosure that notifies the market of an intended sale of restricted shares originally issued by the company. The quantity—2,763 shares—represents a small fraction of the reported 14.7 million shares outstanding, indicating limited potential dilution or market impact from this specific sale. The filing lists acquisition dates and shows the shares were received as restricted stock and paid in full at grant, consistent with typical employee or affiliate equity compensation.
TL;DR: Filing appears procedurally complete but lacks identifying filer contact and named seller information in the public excerpt.
The document follows Rule 144 formatting and includes the broker, share counts, acquisition details, and the seller's representation about material non-disclosure. However, the provided content does not show the filers name or CIK in the visible excerpt, nor the specific identity of the person on whose account the sale is proposed, which are typically present elsewhere in the full filing. From a compliance perspective, the disclosed allocation of grants and the absence of prior sales in the past three months simplify the aggregation and eligibility analysis under Rule 144.